Novo Nordisk 挫折后 Monte Rosa 与 BioAge 股价暴跌 (GLUE:NASDAQ)
· seekingalpha.com
诺和诺德 (NVO) 心脏药物试验失败，引发了市场对 Monte Rosa (GLUE) 和 BioAge Labs (BIOA) 开发的抗炎药物的质疑。点击阅读更多。
Shares of Monte Rosa Therapeutics (GLUE) and BioAge Labs (BIOA) fell sharply on Friday after a late-stage trial setback for Novo Nordisk (NVO) called into quest...